BOSTON and SAN DIEGO —— Partners HealthCare and Illumina, Inc. (NASDAQ:ILMN) today announced the GeneInsight-Illumina Founding Network Members, including the ARUP Laboratories, Mount Sinai Genetic Testing Laboratory, New York Genome Center (NYGC), Partners HealthCare, and Illumina. The members represent a diverse and distinguished group of laboratories within leading academic institutions and commercial organizations who are […]
CAMBRIDGE, MASSACHUSETTS –— IMDx (privately held) announced today that it has entered into a multi-year development and license agreement with QIAGEN (NASDAQ: QGEN, Frankfurt Prime Standard: QIA) to design, develop and manufacture several undisclosed CE-marked and FDA cleared diagnostic tests for use on QIAGEN’s flagship QIAsymphony RGQ automated platform. Financial terms have not been disclosed. […]
CAMBRIDGE, MASSACHUSETTS –— IntelligentMDx (privately held) announced today that it has entered into a multi-year development and license agreement with QIAGEN (NASDAQ: QGEN, Frankfurt Prime Standard: QIA) to design, develop and manufacture several undisclosed CE-marked and FDA cleared diagnostic tests for use on QIAGEN’s flagship QIAsymphony RGQ automated platform. Financial terms have not been disclosed. […]
SAN DIEGO, — Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced preliminary highlights of the Company’s 2012 performance and accomplishments. Initial 2012 Performance Results (unaudited) Total revenue of approximately $89 million, growth of approximately 59 percent year-over-year for 2012 Diagnostic services revenues of approximately $46 […]
SAN DIEGO, — Trovagene, Inc. (NASDAQ: TROV), a developer of transrenal molecular diagnostics, announced it has granted Duke University and Duke University Health Systems a non-exclusive license to incorporate nucleophosmin protein (NPM1) into research and clinical testing services for acute myelogenous leukemia (AML). Trovagene holds an exclusive worldwide license to U.S. patent 8,222,370 and the […]
SUNNYVALE, Calif., — Cepheid (NASDAQ: CPHD) today announced that it has received clearance from the U.S. Food & Drug Administration (FDA) to market Xpert® CT/NG. Running on Cepheid’s GeneXpert® Systems, Xpert CT/NG is a qualitative in vitro molecular diagnostic test for the detection and differentiation of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG). For the […]
Franklin Lakes, NJ – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it has completed its acquisition of Safety Syringes, Inc., a privately held California-based company that specializes in the development of anti-needlestick devices for prefilled syringes. The financial terms were not disclosed. The acquisition broadens BD’s […]
Dako, an Agilent Technologies company, has signed an agreement to acquire the intellectual property rights behind connectivity software from California-based software development company System Dynamics, Inc. (SDI). The SDI development team joins Dako and brings new software development competencies to one of the world’s leaders in cancer diagnostics. “The acquisition of the intellectual property rights […]
Hackensack University Medical Center is now the first hospital in the nation to receive state approval to report microbiological clinical results using the bioMérieuxVITEK® MS device. “We are excited to be the first medical center in the nation approved to report such important clinical data obtained through the VITEK MS platform,” said Robert C. Garrett, […]
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the global launch (excluding US) of cobas b 101, a new system for the diagnosis and management of metabolic syndrome. Designed for use at the point of care – at the doctor’s office or outpatient clinic – the new cobas b 101 system is the only system […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
